Department of Biomedicine and Prevention
  • Homepage
  • Department
    • Organization and Governance
    • Council of the Department
    • Commissions
    • Staff
  • Research
  • Didactic
    • Scuola di Specializzazione in Scienza dell' Alimentazione
    • Scuola di Specializzazione di Igiene e Medicina Preventiva
    • Scuola di Specializzazione in Radioterapia
    • Scuola di Specializzazione di Radiodiagnostica
    • Scuola di Specializzazione in Ematologia
    • Medical genetics Graduated School
    • master_II_Level_Cytogenetics
    • master_II_Level_CBRNE
    • master_I_Level_PH. E. SOUCHARD
    • master_I_Level_CBRNE
    • master_I_Level_Nursing_Managment
    • master_I_Level_Critical_Nursing
    • master_I_Level_Stomaterapia
    • Corso_professionale_Nursery_midwifery_operating_room
  • Third Mission
    • Conventions
    • Laboratory of Environmental Microbiology
    • Environmental Chemistry Laboratory
    • ICP-Massa Laboratory
    • Laboratory of Forensic Genetics
    • Laboratory of Industrial Hygiene
    • Laboratory of Medical Genetics
    • Laboratory of Oncohematology
    • Section of Histology and Embryology-Laboratories of Reproductive and Developmental Biology
    • Section of Legal Medicine
    • Simulation and Optimization Laboratory of National Health Service (SSN) Services
    • Laboratory for Primordial Cell Germ Study en
    • Laboratory for the Prevention and Management of Psychosocial Risks (stress, mobbing and burn out)
    • Laboratory of Environmental and Occupational Toxicology
    • Laboratorio of Human Anatomy
  • SUA-RD_en
    • Report on Research Planning 2014-2015
    • Research Report
    • Papers on SCOPUS
    • Statistics and Metrics
    • Research lines
  • Positions and Announcements
    • Positions
    • Commitments to third parties
  • In Evidence
  • News_en
  • Home
  • Dipartimento
    • Organizzazione e Governance
    • Giunta di Dipartimento
    • Commissioni
    • Personale
  • Ricerca
    • Dottorati di ricerca
  • Didattica
    • Scuola di Specializzazione in Scienza dell' Alimentazione
    • Scuola di Specializzazione di Igiene e Medicina Preventiva >
      • LIBRETTO SCUOLA SPECIALIZZAZIONE
    • Scuola di Specializzazione in Radioterapia
    • Scuola di Specializzazione di Radiodiagnostica
    • Scuola di Specializzazione in Ematologia
    • Scuola di Specializzazione in Genetica Medica
    • master_II_Livello_Citogenetica
    • master_II_Livello_CBRNE
    • master_I_Livello_PH. E. SOUCHARD
    • master_I_Livello_CBRNE
    • master_I_Livello_Nursing_Managment
    • master_I_Livello_Critical_Nursing
    • master_I_Livello_Stomaterapia
    • Corso_professionale_Infermiere_Ostetrica_sala_operatoria
  • Terza Missione
    • Convenzioni
    • Laboratorio di Microbiologia Ambientale
    • Laboratorio di Chimica Ambientale
    • Laboratorio ICP-Massa
    • Laboratorio di Genetica Forense
    • Laboratorio di Genetica Medica
    • Sezione di Medicina Legale
    • Laboratorio di Oncoematologia
    • Laboratorio di Igiene Industriale
    • Laboratory for Primordial Cell Germ Study
    • Laboratorio dei Rischi Psicosociali
    • Sezione di Istologia ed Embriologia - Laboratorio di Biologia della Riproduzione e dello Sviluppo
    • Laboratorio di Simulazione - SSN
    • Laboratorio di Tossicologia Ambientale ed Occupazionale
    • Laboratori Sezione di Biologia
    • Laboratory of Human Anatomy
  • SUA-RD
    • Relazione Ricerca
    • Relazione Programmazione Ricerca
    • Elenco Pubblicazioni Scopus
    • Statistiche e Metriche
    • Linee di Ricerca
  • News
  • Bandi e Concorsi
    • Concorsi
    • Affidamento incarichi c/terzi
  • In Evidenza
  • Area riservata

TOR VERGATA: PROTEIN KEY TO HALTING SMA SYMPTOMS DISCOVERED 

8/3/2017

0 Comments

 
Foto
ROME – A group of researchers from the University of Rome “Tor Vergata” and the Fondazione Santa Lucia has identified a potential new approach to treating spinal muscular atrophy (SMA) which directly tackles the gene mutation responsible for the disease.
The study, funded by the Fondazione Telethon, was coordinated by Claudio Sette, Associate Professor at the Department of Biomedicine and Prevention, University of Rome “Tor Vergata”. The study’s findings have appeared in the scientific publication The Journal of Cell Biology.
Spinal muscular atrophy (SMA) is a neuromuscular disease characterized by the progressive death of motor neurons, the nerve cells in the spinal cord that relay motor commands to the muscles. The disease is caused by mutations in the genes called SMN1 and SMN2, which lead to the production of insufficient levels of the SMN protein that is associated with the survival of motor neurons. To date, all attempts to correct the genetic defect responsible have failed to yield the desired results.
The research group led by Claudio Sette had already in recent years identified a protein, called Sam68, involved in certain processes key to the progression of the disease. In this new study, the researchers developed animal (mouse) models of SMA in which Sam68 was eliminated. They were thus able to observe that mice lacking the Sam68 protein showed a significant improvement in the survival of motor neurons and, more generally, in the health and functionality of affected muscles. This thus paves the way for a new therapeutic approach to this as-yet incurable disease, in respect of which however very interesting prospects have emerged in recent years thanks to research. In particular, at the start of 2015 two international clinical trials got underway, in which Italian patients will also be able to participate, testing the efficacy of two different drugs in combating the disease. According to a statement issued by the University of Rome “Tor Vergata”, this undertaking has in part been made possible with the support of the Fondazione Telethon.
Spinal muscular atrophy (SMA) – Spinal muscular atrophy (SMA) is a neuromuscular disease characterized by the progressive death of motor neurons, the nerve cells in the spinal cord that control muscle movement.
It affects around 1 in every 10,000 newborn babies and is the most common genetic cause of infant death. There are three forms of the disease, of which type I is the most serious and affects about half of SMA patients. In this type, affected infants exhibit signs of the disease already from birth or within their first few months of life, manifesting as severe and progressive signs of respiratory insufficiency.
Children suffering from type II, also termed the “intermediate form”, acquire the ability to sit but not to walk unaided, and often present respiratory complications as well as other signs, such as scoliosis.
Type III is the least severe, often begins to manifest after the first few years of life, and is always accompanied by successful development of the ability to walk, although in some cases this capability may subsequently be lost.
The disease is caused by a defect in the SMN1 gene that encodes for a protein called SMN. The counterpart SMN2 gene remains functional in SMA patients, but leads to the production of insufficient levels of the SMN protein.
The mode of transmission is autosomal recessive: parents are healthy carriers of the genetic defect and have a 25% probability of transmitting the disease to each of their children. The disease is diagnosed through genetic testing. At present, there is no definitive cure, though numerous studies are underway to evaluate potential treatments. A few drugs are currently being trialed.
 
0 Comments



Leave a Reply.

    REPOSITORY

    July 2018
    June 2018
    May 2018
    March 2018
    February 2018
    December 2017
    November 2017
    October 2017
    September 2017
    May 2017
    April 2017
    March 2017

    RSS Feed

​Dipartimento di Biomedicina e Prevenzione
Università di Roma Tor Vergata 

presso Facoltà di Medicina e Chirurgia
Indirizzo:  Viale Montpellier, 1 – Roma
Direttore del Dipartimento
Prof. Antonio De Lorenzo


Responsabile Amministrativo
Avv. Ombretta Picchioni


Content manager del sito
Ing. Andrea Malizia
  • Homepage
  • Department
    • Organization and Governance
    • Council of the Department
    • Commissions
    • Staff
  • Research
  • Didactic
    • Scuola di Specializzazione in Scienza dell' Alimentazione
    • Scuola di Specializzazione di Igiene e Medicina Preventiva
    • Scuola di Specializzazione in Radioterapia
    • Scuola di Specializzazione di Radiodiagnostica
    • Scuola di Specializzazione in Ematologia
    • Medical genetics Graduated School
    • master_II_Level_Cytogenetics
    • master_II_Level_CBRNE
    • master_I_Level_PH. E. SOUCHARD
    • master_I_Level_CBRNE
    • master_I_Level_Nursing_Managment
    • master_I_Level_Critical_Nursing
    • master_I_Level_Stomaterapia
    • Corso_professionale_Nursery_midwifery_operating_room
  • Third Mission
    • Conventions
    • Laboratory of Environmental Microbiology
    • Environmental Chemistry Laboratory
    • ICP-Massa Laboratory
    • Laboratory of Forensic Genetics
    • Laboratory of Industrial Hygiene
    • Laboratory of Medical Genetics
    • Laboratory of Oncohematology
    • Section of Histology and Embryology-Laboratories of Reproductive and Developmental Biology
    • Section of Legal Medicine
    • Simulation and Optimization Laboratory of National Health Service (SSN) Services
    • Laboratory for Primordial Cell Germ Study en
    • Laboratory for the Prevention and Management of Psychosocial Risks (stress, mobbing and burn out)
    • Laboratory of Environmental and Occupational Toxicology
    • Laboratorio of Human Anatomy
  • SUA-RD_en
    • Report on Research Planning 2014-2015
    • Research Report
    • Papers on SCOPUS
    • Statistics and Metrics
    • Research lines
  • Positions and Announcements
    • Positions
    • Commitments to third parties
  • In Evidence
  • News_en
  • Home
  • Dipartimento
    • Organizzazione e Governance
    • Giunta di Dipartimento
    • Commissioni
    • Personale
  • Ricerca
    • Dottorati di ricerca
  • Didattica
    • Scuola di Specializzazione in Scienza dell' Alimentazione
    • Scuola di Specializzazione di Igiene e Medicina Preventiva >
      • LIBRETTO SCUOLA SPECIALIZZAZIONE
    • Scuola di Specializzazione in Radioterapia
    • Scuola di Specializzazione di Radiodiagnostica
    • Scuola di Specializzazione in Ematologia
    • Scuola di Specializzazione in Genetica Medica
    • master_II_Livello_Citogenetica
    • master_II_Livello_CBRNE
    • master_I_Livello_PH. E. SOUCHARD
    • master_I_Livello_CBRNE
    • master_I_Livello_Nursing_Managment
    • master_I_Livello_Critical_Nursing
    • master_I_Livello_Stomaterapia
    • Corso_professionale_Infermiere_Ostetrica_sala_operatoria
  • Terza Missione
    • Convenzioni
    • Laboratorio di Microbiologia Ambientale
    • Laboratorio di Chimica Ambientale
    • Laboratorio ICP-Massa
    • Laboratorio di Genetica Forense
    • Laboratorio di Genetica Medica
    • Sezione di Medicina Legale
    • Laboratorio di Oncoematologia
    • Laboratorio di Igiene Industriale
    • Laboratory for Primordial Cell Germ Study
    • Laboratorio dei Rischi Psicosociali
    • Sezione di Istologia ed Embriologia - Laboratorio di Biologia della Riproduzione e dello Sviluppo
    • Laboratorio di Simulazione - SSN
    • Laboratorio di Tossicologia Ambientale ed Occupazionale
    • Laboratori Sezione di Biologia
    • Laboratory of Human Anatomy
  • SUA-RD
    • Relazione Ricerca
    • Relazione Programmazione Ricerca
    • Elenco Pubblicazioni Scopus
    • Statistiche e Metriche
    • Linee di Ricerca
  • News
  • Bandi e Concorsi
    • Concorsi
    • Affidamento incarichi c/terzi
  • In Evidenza
  • Area riservata